Halozyme Therapeutics Inc. | Key People and Executives
Helen I. Torley
President, Chief Executive Officer & Director
Bernadette M. Connaughton
Director
Connie L. Matsui
Chairman
Jeffrey William Henderson
Independent Director
James M. Daly
Independent Director
Jean-Pierre Bizzari
Independent Director
Kenneth J. Kelley
Independent Director
Matthew L. Posard
Independent Director
Helen I. Torley
President, Chief Executive Officer & Director
David A. Ramsay
Chief Financial Officer
Dimitrios Chondros
Chief Medical Officer & Senior Vice President
Michael J. LaBarre
Chief Scientific Officer & Vice President
Harry J. Leonhardt
Secretary, Chief Compliance Officer & Senior VP
Benjamin Joseph Hickey
Chief Commercial Officer
Renee P. Tannenbaum
Vice President-Global Alliances
Homa Yeganegi
Vice President-Global Scientific & Medical Affairs
William J. Fallon
Vice President-Manufacturing & Operations
Ed Gemo
Chief Information Officer & Vice President
Bernadette M. Connaughton
Director
James S. Mazzola
VP-Corporate Communications & Investor Relations
Michael E. Paolucci
Chief Human Resources Officer & Vice President
Kristina Vlaovic
Vice President-Regulatory & Safety
Connie L. Matsui
Chairman
Jeffrey William Henderson
Independent Director
James M. Daly
Independent Director
Jean-Pierre Bizzari
Independent Director
Kenneth J. Kelley
Independent Director
Matthew L. Posard
Independent Director
| Address |
11388 Sorrento Valley Road
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.halozyme.com |
| Updated |
07/08/2019 |
| Halozyme Therapeutics, Inc. is a biopharmaceutical company specializes in research, development, and commercialization of human enzymes and other drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. |
